Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

Genetics and Biology of Brain Cancers

December 13 - 15, 2009

Omni San Diego Hotel

San Diego, California


Lynda Chin, Dana-Farber Cancer Institute, Boston, MA

Webster K. Cavenee, UCSD Moores Cancer Center, La Jolla, CA

Paul S. Mischel, David Geffen School of Medicine at UCLA, Los Angeles, CA

Mitchel S. Berger, University of California, San Francisco, CA


This conference will bring basic, genomic, and translational scientists together with clinicians to discuss how to develop more effective molecularly targeted therapies for brain tumor patients based on a mechanistic understanding of the molecular circuitry of the disease.  In addition to the invited speakers, each session will feature two oral presentations selected for submitted abstracts on "hot-topics" science and exciting new discoveries. 



*       Plenary session: Defining the Clinical Problems

*       Pediatric Brain Tumors: Developmental Origin and Clinical Implication

*       Adult Brain Tumor: Developmental Origin and Clinical Implication

*       Modeling Brain Tumors In Vivo: Preclinical Therapeutics

*       Genomics and Genetics of Brain Cancers: Approaches to "Personalize" Brain Tumor Therapy

*       Special TCGA Session: Genomics of Brain Cancers: A TCGA Update

*       Translational Neuro-Oncology: Targeted Therapies and Resistance

*       Translational Neuro-Oncology: Drug Delivery and Imaging




Organizer American Association for Cancer Research


Sun, Dec. 13 - Tue, Dec. 15, 2009
8:30 a.m. - 5:30 p.m.
(GMT-0500) US/Central


American Association for Cancer Research